Alejandro I. Recio-Balsells

Dr. Alejandro I. Recio-Balsells

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 November 2020 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
JLJulia Fernández de Luco
Julia Fernández de Luco
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
DGDiego G. Ghiano
Diego G. Ghiano
ABAna Bortolotti
Ana Bortolotti
Juan BelardinelliJuan Belardinelli
Juan Belardinelli
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
Triclosan and isoniazid are known antitubercular compounds that have proven to be also active against Leishmania parasites. On these grounds, a collection of 37 diverse 1,2,3-triazoles based on the antitubercular molecules triclosan and 5-octyl-2-phenoxyphenol (8PP) were designed in search of novel structures with leishmanicidal activity and prepared using different alkynes and azides. The 37 compounds were assayed against Leishmania donovani, the etiological agent of leishmaniasis, yielding some analogs with activity at micromolar concentrations and against M. tuberculosis H37Rv resulting in scarce active compounds with an MIC of 20 μM. To study the mechanism of action of these catechols, we analyzed the inhibition activity of the library on the M. tuberculosis enoyl-ACP reductase (ENR) InhA, obtaining poor inhibition of the enzyme. The cytotoxicity against Vero cells was also tested, resulting in none of the compounds being cytotoxic at concentrations of up to 20 μM. Derivative 5f could be considered a valuable starting point for future antileishmanial drug development. The validation of a putative leishmanial InhA orthologue as a therapeutic target needs to be further investigated.

9 January 2026 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
CRChantal Reigada
Chantal Reigada
MMMaría Gabriela Mediavilla
María Gabriela Mediavilla
EZEsteban Andres Panozzo Zenere
Esteban Andres Panozzo Zenere
MVMiguel Villarreal-Parra
Miguel Villarreal-Parra
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
Introduction: Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a major public health concern due to the limited effectiveness of current treatments, especially in the chronic stage. Objective: Here, we wanted to advance a library of 30 N,N′-disubstituted diamines as promising antichagasic agents and gain insight into the mechanism of action. Methods: The library was evaluated for activity against the T. cruzi amastigote stage and trypanocidal efficacy. In addition, selected compounds were tested as potential polyamine transport inhibitors, and a fluorescent analog was employed to investigate compound internalization. Results: Five compounds exhibited potent activity (pIC50 > 6.0), particularly those with short aliphatic linkers (3–6 carbon atoms), suggesting a structure–activity relationship favouring shorter chains. Mechanistic studies showed that compound 3c strongly inhibited polyamine transport, a vital pathway in T. cruzi, though this was not a universal mechanism among active hits, indicating the potential for multiple targets. A fluorescent analog confirmed intracellular uptake in amastigotes but lacked antiparasitic activity, likely due to disrupted pharmacophoric features. Importantly, none of the compounds demonstrated trypanocidal activity in long-term assays, and some showed cytotoxicity, particularly in the benzyloxy-substituted series. Conclusions: These findings position N,N′-disubstituted diamines as a viable scaffold for Chagas disease drug discovery. However, further optimization is required to enhance selectivity, achieve trypanocidal effects, and better understand the underlying mechanisms of action.

1 September 2018 in Tuberculosis
Verified
Journal Article
Open access
JFJorgelina J. Franceschelli
Jorgelina J. Franceschelli
Juan BelardinelliJuan Belardinelli
Juan Belardinelli
PTPing Tong
Ping Tong
Brendan LoftusBrendan Loftus
Brendan Loftus
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
HMHector R. Morbidoni
Hector R. Morbidoni
Clinical isolates of Mycobacterium tuberculosis and Mycobacterium bovis are differentially susceptible to 2-Thiophen Hydrazide (TCH); however its mechanism of action or the reasons for that difference are unknown. We report herein that under our experimental conditions, TCH inhibits M. tuberculosis in solid but not in liquid medium, and that in spite of resembling Isoniazid and Ethionamide, it does not affect mycolic acid synthesis. To understand the mechanisms of action of TCH we isolated M. tuberculosis TCH resistant mutants which fell into two groups; one resistant to TCH and Isoniazid but not to Ethionamide or Triclosan, and the other resistant only to TCH with no, or marginal, cross resistance to Isoniazid. A S315T katG mutation conferred resistance to TCH while katG expression from a plasmid reduced M. tuberculosis MIC to this drug, suggesting a possible involvement of KatG in TCH activation. Whole genome sequencing of mutants from this second group revealed a single mutation in the alkylhydroperoxide reductase ahpC promoter locus in half of the mutants, while the remaining contained mutations in dispensable genes. This is the first report of the genetics underlying the action of TCH and of the involvement of ahpC as the sole basis for resistance to an anti-tubercular compound.

12 September 2024 in Archiv der Pharmazie
Verified
Journal Article
Closed access
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
RCRenzo Carlucci
Renzo Carlucci
SGSimone Giovannuzzi
Simone Giovannuzzi
FCFabrizio Carta
Fabrizio Carta
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie

1 January 2026 in RSC Medicinal Chemistry
Verified
Journal Article
Closed access
ARAlejandro I. Recio-Balsells
Alejandro I. Recio-Balsells
GGGabriel Di Gresia
Gabriel Di Gresia
MMMarcelo Luciano Merli
Marcelo Luciano Merli
JCJulia Alejandra Cricco
Julia Alejandra Cricco
HMHector R. Morbidoni
Hector R. Morbidoni
GLGuillermo Roberto Labadie
Guillermo Roberto Labadie
The emergence of drug-resistant Mycobacterium tuberculosis strains and non-tuberculous mycobacteria (NTM) species such as Mycobacterium abscessus, highlights the urgent need for new chemotypes with broad-spectrum antimycobacterial activity. In this study,...